Past events
Previous events in the Metrion calendar
Metrion Biosciences holds and participates in numerous events each year for professional development, knowledge sharing, self-improvement and networking opportunities. Below you will find a list of all our previous events, please follow the links to find out more information about any of them.
You will find reviews of many of our past events within our ConnectIONS blog section of the Metrion website, alongside a selection of great interviews, articles and insights from our team and distinguished guests.
Metrion Biosciences and AstraZeneca are co-organising the Cambridge Ion Channel Forum (CICF) taking place on Wednesday 10th May 2023.
The event will take place at the Cambridge Building at the Babraham Research Campus Conference Centre in Cambridge. The event will comprise a networking lunch, a series of talks, a networking coffee break and a poster session plus a drinks reception.
Metrion Biosciences is attending the 34th Medicinal Chemistry in Eastern England conference, taking place on 27th April 2023 at the Fielder Centre in Hatfield, UK.
Metrion’s Sales and Marketing Manager, Dr Sophie Rose will be attending the meeting and if you would like to meet with themher, please email info@metrionbiosciences.com.
Known colloquially as the “Hatfield MedChem” meeting, this is a highly successful, long-standing, one-day meeting that runs annually. The scientific program will comprise presentations showcasing medicinal chemistry case studies from tools to candidates, across a range of modalities, therapeutic areas and target classes, as well as covering more general topics at the forefront of drug discovery. The meeting aims to be informal and interactive, and is ideal for all those working in medicinal chemistry and drug discovery more widely.
Metrion Biosciences are attending Empowering Women in Biotech, taking place on 18th April 2023 at Charnwood Molecular in Loughborough, UK.
Metrion’s Sales and Marketing Manager, Dr. Sophie Rose will be attending the meeting and if you would like to meet with her, please email info@metrionbiosciences.com.
Share personal and professional experiences and career strategies from a woman’s perspective
Help women, wherever they are in the career paths, realise their future goals.
Encourage women to enter and maintain careers in Biotech.
Generate a wider network of professionals working in Biotech
An all inclusive event where all are welcome especially:
-Women in academia and industry who would like to network
-Women who would like to learn about and explore the opportunities available to them
Metrion Biosciences are attending the Research and Innovation 2023 Conference, taking place on 29th and 30th March 2023 at the Wellcome Genome Campus, Cambridge.
Metrion will have a delegate attending the meeting and if you would like to meet with them, please email info@metrionbiosciences.com.
The 2023 ELRIG Research & Innovation conference will discuss how emerging biology and cutting-edge technologies are pioneering the medicines of tomorrow. Bringing together scientists, researchers and entrepreneurs with bold ideas to serve our shared ambitions in creating the next generation of therapeutics to cure more patients around the world. The 2023 R&I meeting will focus on cutting edge innovation, comprising the following four main sessions:
1 – Synthetic biology
2 – Healthy ageing
3 – AI driven drug discovery
4 – Ultra-rare disease drug discovery and personalized therapies
Metrion Biosciences is sponsoring and attending the 7th RSC-BMCS / SCI Symposium on Ion Channels as Therapeutic Targets, taking place on 27th and 28th March 2023 at the Wellcome Genome Campus, Hinxton, Cambridge.
Metrion’s Dr Alexandra Pinggera will be presenting at this meeting and if you would to meet with her please email info@metrionbiosciences.com.
Metrion will have a booth at the event and we would be delighted if you would stop by to say hello to our Chief Commercial Officer, Nick Foster and Sales and Marketing Manager, Sophie Rose.
Summary: Ion channels are important targets for therapeutic intervention due to their extensive roles in human physiology and the pathophysiology of disease. Many successful drugs targeting this gene family have been discovered for diseases such as hypertension, epilepsy and neuropathic pain.
This symposium, the 7th in an ongoing series, will showcase the most recent advances to aid the design of new ion channel therapeutics and promote interaction between scientists with a shared interest in the field of ion channel drug discovery.
Metrion Biosciences is attending the SOT 62nd Annual Meeting and ToxExpo, taking place on 19th – 23rd March 2023 at The Nashville Music City Centre.
Metrion’s Chief Commercial Officer, Nick Foster and Senior Scientist II, Ray Tang will be attending this meeting and will be at Booth number 1545. If you would to meet with Nick and Ray, please email info@metrionbiosciences.com.
Summary: More than 70 Featured and Scientific Sessions will take place in a friendly, relaxed atmosphere alongside 2,000+ poster presentations and the three-day ToxExpo featuring 250 companies.
Metrion Biosciences is sponsoring and attending the 2023 Biophysical Society Annual Meeting taking place at the San Diego Convention Center, 111 W Harbor Dr, San Diego, CA 92101, USA from 18th to 22nd February 2023.
Metrion’s Dr. Gary Clark and Dr. Nicola Secomandi will be attending the meeting. If you would like to meet with them, please email info@metrionbiosciences.com. Metrion will have a booth at the event, number 203. Please stop by to discuss your requirements with Gary and Nicola.
Metrion will also be sponsoring the ‘Drug Discovery for Ion Channels XXIII’ Satellite meeting taking place on Friday 17th February 2023 in Room 8 at the San Diego Convention Center.
The Biophysical Society annual meetings are the largest annual gathering of biophysicists around the world. The meetings include symposia, workshops, 15 subgroup programs, over 500 platform speakers selected from submitted abstracts, the Biophysical Society Lecture, more than 4,000 packed poster presentations, as well as educational exhibits, exhibitor presentations, and career development sessions.
Metrion Biosciences’ Chief Commercial Officer, Nick Foster, and Head of Operations, Dr. Robert Kirby, will be attending the 2023 Japanese Safety Pharmacology Annual Meeting taking place at the Yayoi Auditorium, The University of Tokyo, Ichijo Hall from 17th to 18th February 2023.
If you would like to arrange a meeting with either Nick or Rob, please email info@metrionbiosciences.com.
The Japanese Safety Pharmacology annual meeting will include multiple symposiums, lectures, workshops, poster presentations, and an excellent presentation award ceremony.
Genesis 2022
December 7th
Metrion Biosciences’ Chief Commercial Officer, Nick Foster, is attending the GENESIS Conference, taking place on 7th December 2022 at the Royal Society of Medicine on Wimpole Street, London.
If you would like to arrange a meeting with Nick, please email info@metrionbiosciences.com.
The annual Genesis conference has been a pillar of the Life Science sector for over two decades. Bringing together key opinion leaders, investors and innovators from across the sector to share insight, debate key trends and generate deals.
The headline theme of the year is “Maximising Returns from Life Science Innovation” the event will feature:
- A keynote programme of presentations and panels provoking debate around the programme theme
- An exhibition area for sponsors to engage with their key client base
- Online 1-2-1 partnering meetings and networking
- Online Innovation Workshops throughout the week
- Satellite event options in the Genesis Fringe
- Ample time for in-person networking
Metrion Webinar – Dr. Manoj Patel
November 29th
Metrion Biosciences “Ion Channels in Drug Discovery” webinar series will take place again this November. Manoj K. Patel, Ph.D, Associate Professor at the University of Virginia will speak about “Gain-of-function mutations in Nav1.6 and epileptic seizures“.
A summary of the talk is given below:
Many de novo missense mutations of SCN8A, the gene that encodes for Nav1.6, have been identified and patients have seizure onset between birth and 12 months of age. Patients with these mutations have seizures that are difficult to control. As such, they have an increased chance of dying unexpectedly from a seizure (SUDEP). My laboratory has begun to evaluate a number of these patient mutations. We have shown that Nav1.6 mutations that are associated with seizure onset are typically gain-of-function (GOF) mutations, while loss-of-function (LOF) mutations are typically associated with intellectual disability (ID) and sometimes absence seizures. Using two mice mouse models of SCN8A epilepsy we have began to evaluate the effects of GOF mutations on both excitatory and inhibitory neurons to better understand how alterations in the biophysical properties of Nav1.6, as a result of a mutation, can facilitate seizure onset.
XIV Spanish Drug Discovery Network Meeting 2022
November 24th
November 25th
Metrion Biosciences is attending the XIV Spanish Drug Discovery Network Meeting, taking place on 24th and 25th November 2022 at Parque Tecnológico de la Salud (PTS) / Universidad de Granada, in Granada, Spain.
Metrion will have a delegate attending the meeting and if you would to meet with them, please email info@metrionbiosciences.com.
The international conference is an ideal forum for the early drug discovery community, both from Academia and Industry. Every year there are a limited number of topics with the idea to facilitate an “in-depth” discussion among professionals with very different backgrounds, but all focused on advancing the frontline of drug discovery and translational medicine research.
This year, the programme will focus on four scientific areas that are continuously evolving and increasingly having an impact on drug discovery:
- Targeted Protein Degradation
- Nucleic Acids as Therapeutic Agents
- Antimicrobial Resistance and New Antibiotics
- Biologics in Drug Discovery and Development.
Included is a Round Table Discussion about “How to potentiate Drug Discovery in Spain”.
Sophion Ion Channel Modulation Symposium 2022 – USA
November 5th
November 6th
Metrion Biosciences is attending the Sophion Ion Channel Modulation Symposium , taking place on 5th and 6th November 2022 at New York University, USA.
Metrion’s VP, US Commercial Operations, Dr Rory Curtis will be attending the meeting and if you would to meet with him, please email info@metrionbiosciences.com.
The Ion Channel Modulation Symposium gathers a broad range of people from academia, CROs and pharmaceutical companies to discuss the science of ion channel modulation. The symposium provides more than 20 speakers with an audience of 130 and has been fully attended in both 2016, 2017, 2018 and 2019.
Speakers will address a spectrum of ion channel topics, such as new therapeutic targets, advances in the understanding of ion channel protein structures, advances in techniques for the study of ion channels and ‘traditional’ ion channel targets such as pain, inflammation, cardiovascular and neurological. The meeting aims to cover a broad range of ion channels and present issues that are important in their modulation for the purpose of drug discovery and look at innovative technologies and approaches to this research.
ELRIG Drug Discovery 2022
October 4th
October 5th
Metrion Biosciences is attending the ELRIG drug discovery meeting, taking place on 4th and 5th October 2022 at the Excel Centre, London.
Metrion will have two delegates attending the meeting, Benedetta Montagnini (Head of European Business Development) and Sophie Rose (Sales and Marketing Manager) and if you would to meet with our representatives please email info@metrionbiosciences.com.
Drug Discovery 2022 promises to provide a platform for the whole drug discovery community to meet at a free to attend, in-person event. ELRIG has partnered with; BPS, SLAS, and RSC to draw together an exciting and progressive 2-day event containing; cutting-edge advancements in screening, automation and high content imaging, and innovations in disease models, advances in cell and gene therapies, revolutions through partnerships, future perspectives in medicinal and green chemistry and finally creative thinking to deliver therapies to one of the most challenging diseases facing society; COPD
Cambridge Neuroscience Seminar
September 29th
September 29th
Metrion Biosciences is attending the Cambridge Neuroscience Seminar, taking place on 29th September 2022 at Fitzwilliam College, Cambridge.
Neuroscience within Cambridge covers a wide array of topics, specialities, disciplines and techniques and it is spread across Departments and Schools. The strategic vision of the Cambridge Neuroscience IRC (Interdisciplinary Research Centre) is to deliver research innovation in neuroscience and enhance health and quality of life.
Central to this vision, is the aim to develop an integrated framework that will promote cutting-edge research in marrying discovery and translational neuroscience, celebrate our diverse and cross-disciplinary approach, bolster our integrative community and attract new funding and talent to develop into new horizons.
BioPharm America 2022
September 28th
September 29th
Metrion Biosciences are attending BioPharm America, taking place on 28th and 29th September 2022 at Boston Convention & Exhibition Center, Boston.
Metrion are excited to take part in opportunities to network, have one-one meetings, attend company presentations and panel discussions and, also attend a start-up springboard where biotech companies get the opportunity to present a 5 slide presentation about their new company.
Safety Pharmacology Society Annual Meeting 2022
September 11th
September 14th
Metrion Biosciences is attending the Safety Pharmacology Society Annual Meeting, taking place from 11th to 14th September 2022 in Montreal, Canada at the Palais de Congres Montreal.
Attendees can expect a dynamic forum for best practice sharing within industry, CRO’s, academics, researchers, students, trainees, clinicians and regulators plus scientific sessions organised by SPS/CSPT Members and plenary keynotes by key opinion leaders.
Pharmacology 2022
September 13th
September 14th
Metrion Biosciences’ Head of European Business Development, Dr Benedetta Montagnini is attending the Pharmacology 2022 conference, taking place between 13th and 14th September at the ACC in Liverpool. This meeting is the highlight of the Society’s year and a chance to connect with hundreds of fellow scientists from across the pharmacology and therapeutics community.
The meeting will allow world-class experts to showcase their science in the plenary sessions, discover the detail in topical themed symposia, and share knowledge and ideas within interactive workshops.
Pharmacology 2022 brings together students, researchers, people working in industry, academics, and clinicians from across the globe to meet, share science, and network.
EFMC-ISMC
September 4th
September 8th
The XXVII EFMC International Symposium on Medicinal Chemistry is organised by the Societe de Chimie Therapeutique (SCT) on behalf of the European Federation for Medicinal Chemistry and Chemical Biology (EFMC).
Metrion look forward to exhibiting at the event which is taking place from 4th to 8th September 2022 in Nice, France.
Registrations are now open. The 2022 programme will cover advances in drug discovery in major therapeutic areas, including bacterial and viral infections, with a particular attention to current and emerging viral pandemics, but also neurodegenerative and cardiovascular diseases, rare diseases and cancer.
Metrion Biosciences is attending the Sophion User Meeting, North America, taking place on 30th and 31st August 2022 at Sophion Bioscience Inc. in Boston, MA.
Metrion’s VP, US Commercial Operations, Dr Rory Curtis will be attending the meeting. To arrange a meeting with Rory, please email info@metrionbiosciences.com.
Metrion are excited to be able to attend this annual meeting, where the latest developments and best practices using the QPatch II and Qube 384 instrumentations will be discussed. This is in addition to the introduction of Sophion’s newest instrument, the QPatch Compact.
Topics will vary from techniques to use with iPSCs on automated patch-clamp instrumentation to cutting-edge new assays on a variety of channels.
Currently neither traditional Pharma nor big tech companies have the full end-to-end capabilities to compete effectively in the future healthcare market alone, which has led to an evident and significant increase in their partnerships. These partnership aims to exploit the many new scientific breakthroughs, to empower consumers to take control of their own health, to increase development of personalised therapies, to speed up drug discovery and ultimately decrease the healthcare cost at the global level.
A panel of experts from industry, CROs, medical charities and VCs will share some of their experiences and lessons learned on how these institutions have developed strategies to deal with this evolving landscapes.
Sophion ICMS
June 22nd
June 23rd
The annual Sophion Bioscience ICMS Meeting was held at Clare College, Cambridge on 22nd and 23rd June 2022.
Metrion exhibited and presented on “Insights from novel manual patch clamp techniques for target validation“at the event.
Biomed Israel
May 10th
May 12th
Metrion Biosciences are attending Biomed Israel 2022, taking place from 10th to 12th May 2022 in Tel Aviv, Israel at the David InterContinental Hotel on Kaufmann Street.
This year’s conference is co-organized by leading Israeli and international healthcare institutions with the objective of exposing participants to thought leaders and experts and allow local and global attendees to mix and exchange knowledge and ideas.
Metrion Webinar – Dr Kris Kahlig
May 5th
May 5th
Dr Kris Kahlig will present “Using Dynamic Action Potential Clamp Modeling of Nav1.2 Variants to Support the Prediction of Clinical Phenotype in DEE.”
Kris Kahlig, Ph.D. is the Head of Biology at Praxis Precision Medicines Inc. a clinical stage biopharmaceutical company translating genetic insights into the development of therapies for patients affected by CNS disorders.
Cambridge Ion Channel Forum (CICF)
May 4th
May 4th
Metrion Biosciences and AstraZeneca are co-organising the Cambridge Ion Channel Forum (CICF) taking place on Wednesday 4th May 2022 from 12 noon onwards.
The event will take place at the Cambridge Building (Conference Centre) at Babraham Research Park in Cambridge. The event will comprise a networking lunch, a series of talks, a networking coffee break and poster session plus a drinks reception.
Drug Discovery Chemistry 2022
April 18th
April 21st
Metrion’s VP, US Commercial Operations, Rory Curtis and Chief Commercial Officer, Nick Foster will be exhibiting at the 17th Annual Drug Discovery Chemistry Meeting to be held in San Diego at the Hilton Bayfront Hotel from 18th to 21st April 2022.
Metrion will be located at Booth number 121 for the duration of the event.
There will be online and in-person participation options for all attendees.
To arrange a meeting with either Rory or Nick please email info@metrionbiosciences.com.
Society of Toxicology – Annual Meeting
March 27th
March 31st
Dr Rory Curtis will be attending the Annual Meeting of the Society of Toxicology Society to be held in San Diego, California.
There will be online and in-person participation options for all attendees. To arrange a meeting with Rory please email info@metrionbiosciences.com.
Drug Discovery for Ion Channels XXII Satellite Meeting (BPS event)
February 18th
February 18th
Metrion’s Head of Client Research Services Dr Robert Kirby and VP, US Commercial Operations, Dr Rory Curtis will be attending the “Ion Channels in Drug Discovery” Satellite Meeting which takes place on Friday 18th February 2022.
If you would like to arrange a meeting with one of Metrion’s representatives at the event, please email info@metrionbiosciences.com
66th Biophysical Society Annual Meeting 2022
February 19th
February 23rd
Metrion’s Head of Client Research Services Dr Robert Kirby and VP, US Commercial Operations, Dr Rory Curtis will be attending the 66th Biophysical Society Annual Meeting from 19th to 23rd February 2022. Metrion will have a booth at the event, number 529.
If you would like to arrange a meeting with either Rob or Rory at the event, please email info@metrionbiosciences.com
Metrion Webinar – Dr Greg Carr
February 3rd
Dr Greg Carr from the Lieber Institute for Brain Development (LIBD) will present “A role for hERG potassium channels in cognitive function” on Thursday 3rd February, 2022 at 16:00.
If you would like to attend the webinar, please sign up here: https://attendee.gotowebinar.com/register/4640185779264139277
Genesis 2021
December 6th
December 10th
Metrion’s Sales and Marketing Manager, Dr Sophie Rose will be attending Genesis 2021, taking place from 6th to 10th December at 1, Wimpole Street, London and also virtually. Sophie will be attending as a virtual delegate.
Metrion Webinar – Prof. David Sheppard
November 30th
November 30th
The next webinar in the ‘Ion Channels in Drug Discovery’ Webinar Series will be presented by Professor David Sheppard from the University of Bristol.
David will present on the topic “Cystic Fibrosis: Rescuing Faulty Channels with Targeted Therapies”
David N. Sheppard is Professor of Physiology at the University of Bristol. He investigates the cystic fibrosis transmembrane conductance regulator (CFTR), its dysfunction in cystic fibrosis (CF) and rescue with small molecules.
ELRIG Discovery Technologies 2021
November 9th
November 10th
Metrion’s Business Development Executive Anca Haralambie will be attending the ELRIG Discovery Technologies event held at Alderley Park on 9th and 10th November 2021.
With the rapid advancement of new technologies, the potential for developing life changing therapeutic interventions has never been so promising. With these possibilities new challenges arise, not least how to prosecute drug discovery campaigns against new and novel targets and those previously deemed intractable.
This conference will explore evolving early drug discovery technologies to overcome these obstacles by focusing on three core themes: Emerging Discovery Strategies, Hit Triage and Mass Spectrometry and Biophysical Approaches.
ELRIG Drug Discovery 2021
October 19th October 20th
Metrion Biosciences’ Business Development Executive, Anca Haralambie and Scientist Dr Charlotte Hill will be attending the event ” ELRIG Drug Discovery 2021: AFTER THE STORM: RE-CONNECT, RE-INVENT, RE-IMAGINE ” on Tuesday 19th and Wednesday 20th October 2021.
Safety Pharmacology Society – Virtual Annual Meeting
October 4th
October 8th
The Safety Pharmacology Society Virtual Meeting will be taking place from 4th to 8th October 2021. Metrion will have an exhibition booth at the event, please keep an eye on our website for further details.
If you would like to arrange a virtual chat with a Metrion booth representative at the meeting please email info@metrionbiosciences.com
Nuvisan Event – Building the new Pharma Ecosystem
September 29th September 30th
This virtual conference aims at connecting topics and scientists across the pharma, biotech, venture capital, and CRO industries to discuss the recent promises and challenges of the new pharma ecosystem…
Nanion User Meeting 2021
September 29th September 30th
Nanion Technologies are hosting their User Meeting from 29th to 30th September 2021. This will be a hybrid event with a virtual and an in-person presence (Munich, Germany). We will keep you updated on Metrion’s participation over the coming weeks – please watch this space.
If you would like to arrange a meeting with Metrion’s representatives at the event, please contact info@metrionbiosciences.com
Sophion Virtual User Meeting
September 23rd September 23rd
Sophion are hosting their European User meeting virtually in 2021 using Demio. The link adjacent can be used to find out more information about the meeting.
Metrion’s Head of Drug Discovery, Dr Eddy Stevens, will be presenting a talk, please see the full event description below…
Second Metrion Webinar – Professor Stephen Tucker
September 16th
The second Speaker in the webinar series will be Professor Stephen Tucker, Stephen holds the position of Professor of Biophysics at the University of Oxford and is also the Director of the OXION PhD Programme (Ion Channels and Transporters in Health & Disease).
ELRIG Networking event – working with CROs
September 15th
The outsourcing of all or specific activities associated with the drug discovery process is now commonplace within the industry, irrespective of the size of the organisation, sector or geography. This expansion in demand for externalisation of services has been met with an increasing number of providers ranging from large “one-stop-shop” providers through to specialist, or niche, providers focussing on specific activities…
On Helix Digital 2021
July 5th
July 6th
Metrion Biosciences’ Business Development Executive Anca Haralambie will be attending On Helix Digital 2021 which takes place on 5th and 6th July.
On Helix is the One Nucleus flagship conference, bringing together professionals within the One Nucleus network to present and discuss the main innovation and technology trends in healthcare research and development.
Throughout the one and a half days of ON Helix, speakers will address the latest innovations and technologies in Medicines Discovery in a Brave New World.
Translating Ideas into Therapies 2021
June 30th
July 1st
Metrion’s Sales and Marketing Manager Dr Sophie Rose and Business Development Executive Anca Haralambie will be attending “Translating Ideas into Therapies 2021”, Co-hosted by ELRIG and the British Pharmacological Society. The event takes place between Wednesday, 30th June 2021 and Thursday, 1st July 2021 and will be held virtually.
First Metrion Webinar “Discovery of KNa1.1 channel inhibitors using virtual screening and CryoEM structures”
June 29th
Metrion Biosciences is pleased to announce it will be hosting a brand new webinar series starting on Tuesday 29th June at 14:00 BST.
The first Speaker in the webinar series will be Dr Jon Lippiat from the School of Biomedical Sciences at the University of Leeds.
Jon will present on the topic: “Discovery of KNa1.1 channel inhibitors using virtual screening and CryoEM structures”
Saniona Research and Development Day
May 20th
Saniona are hosting a virtual R&D day, taking place on Thursday 20th May at 17.00 CEST/ 11am EDT. This event will be attended by Dr Sophie Rose, Metrion’s Sales and Marketing Manager and Anca Haralambie, Business Development Executive.
The event will focus primarily on Saniona’s ion channel drug discovery programmes and early-stage pipeline.
Nanion Technologies Research Insights Cardiac Safety Symposium 2021
May 19th
May 20th
Metrion Biosciences’ Sales and Marketing Manager Dr Sophie Rose and Business Development Executive Dr Anca Haralambie will be attending the Nanion Technologies Research Insights Cardiac Safety Symposium taking place on Wednesday 19th and Thursday 20th May 2021 on Hopin.
This 2-day interactive online event is focused on Current Challenges in Safety Pharmacology and Cardiac Physiology, in-silico modelling and Best Practices and Evolvements of Safety Pharmacology Methods.
CPhI Discover
May 17th
May 28th
Metrion Biosciences’ Business Development Executive Anca Haralambie will be attending the Virtual CPhI Discover event taking place from 17th to 28th May 2021.
CPhI Discover will be an online event to provide pharmaceutical professionals a way to meet, discuss, partner, source and learn online.
Week 1 (Tuesday 18th to Thursday 20th May) features 3 days of scientific content, whilst week 2 features 5 days of online networking.
Nordic Life Science Days Digital 2021
April 20th
April 23rd
Metrion’s Business Development Executive Anca Haralambie will be attending Nordic Life Science Days to be held virtually from 20th to 23rd April 2021. More details of the event can be found here. If you would like to arrange a partnering meeting with Anca please email info@metrionbiosciences.com
CRISPR in Drug Discovery – ELRIG virtual event
March 23rd March 24th
Metrion’s Sales and Marketing Manager Dr Sophie Rose and Business Development Executive Anca Haralambie will be attending the third CRISPR in Drug Discovery: From Targets to Therapeutics meeting hosted by ELRIG, to be held on 23rd and 24th March 2021 as a virtual event. The event will focus on the application of genome engineering.
One Nucleus Webinar – “Collaborating to Support Biotech and MedTech Business”
March 2nd 2021
Metrion’s Sales and Marketing Manager Dr Sophie Rose is attending the One Nucleus collaborative event with Medilink Midlands on “Collaborating to Support Biotech and Med Tech Business Across Our Neighbouring Regions” on March 2nd at 10-11am. The event is focused on how our two respective groups can collaborate more to support One Nucleus members.
Biophysical Society Annual Meeting 2021
February 22nd
February 26th
Metrion Biosciences will be attending the Biophysical Society Annual Meeting to be hosted virtually from 22nd to 26th February 2021. Metrion will be presenting two posters and taking part in the virtual exhibition at the event.
Please keep an eye on our website for more information as the event date approaches.
Ion Channels in Drug Discovery XXII Virtual Meeting
February 18th
Metrion is co-organising and attending the ‘Drug Discovery for Ion Channels XXII’ Virtual satellite meeting. This is a collaborative meeting, organised alongside partners Nanion, Sophion, Fluxion and SB Drug Discovery.
The final line-up of Speakers will be confirmed very shortly.
The event will start at 8AM PST / 5PM CET, with exact timimgs of specific talks to be confirmed.
Genesis Digital 2020
December 10th, 2020
Metrion’s Sales and Marketing Manager Dr Sophie Rose will be attending Genesis Digital 2020, hosted by One Nucleus. To arrange a meeting with Sophie at the event, please email info@metrionbiosciences.com. Metrion Biosciences is a UK-based Contract Research Organization (CRO) located within the Cambridge bio cluster, one of Europe’s largest bioscience research hubs.
Nanion User Meeting Virtual Event 2020
October 12th October 16th
Metrion Biosciences are attending the Virtual Nanion User Meeting to be held on 12th to 16th October 2020. Metrion’s CSO Dr Marc Rogers will be presenting a talk at the event on 14th October entitled: Development and validation of ASIC1a ligand-gated ion channel drug discovery assays on automated patch clamp platforms.
ELRIG Drug Discovery Digital 2020
October 6th October 7th
Metrion Biosciences will be attending the virtual ELRIG Drug Discovery 2020 meeting taking place between 6th and 16th October 2020. Please email info@metrionbiosciences.com if you wish to arrange a meeting with one of our attendees. Metrion Biosciences is a UK-based Contract Research Organization (CRO) located within the Cambridge bio cluster.
Safety Pharmacology Society Annual Meeting (2020)
September 14th September 17th
Metrion Biosciences look forward to attending, presenting posters and exhibiting at the Virtual Safety Pharmacology Society (SPS) Annual Meeting to be held from 14th to 17th September 2020. Metrion will be located at Booth # 400 in the exhibits hall for the duration of the virtual event. Our collaborative poster with Nanion Technologies.
Metrion-Nanion Collaborative Webinar: Validation and optimisation of automated patch clamp voltage-gated Ca2+ channel assays
April 28th
Metrion Biosciences and Nanion Technologies look forward to hosting their first collaborative webinar on Tuesday 28th April entitled: Validation and optimization of automated patch clamp voltage-gated Ca2+ channel assays. The webinar will feature Metrion’s CSO Dr. Marc Rogers. Marc will outline the development, optimisation and validation of a range of voltage-gated Ca2+ channel assays
RSC Ion Channel Symposium
February 24th February 25th, 2020 @ 5:00 pm
Metrion Biosciences are sponsoring and exhibiting (booth number to be added at a later date) at the RSC Ion Channel Symposium taking place from Monday 24th – Tuesday 25th February 2020 at the Wellcome Trust Genome Campus Conference Centre, Hinxton, Cambridge. Metrion will also be presenting a poster.
64th Annual Meeting of the Biophysical Society
February 15th February 19th
Metrion Biosciences will be attending and exhibiting at the 64th Annual Meeting of the Biophysical Society to be held at the San Diego Convention Centre in San Diego, California from 15th – 19th February 2020. Metrion will be exhibiting at booth number 214 in the Exhibits Hall for the duration of the meeting.
ELRIG Drug Discovery 2019
November 5th November 6th
Metrion Biosciences will be attending ELRIG Drug Discovery 2019 to be held at the ACC Arena, Liverpool on 5th and 6th November 2019. Dr Marc Rogers, Chief Scientific Officer, will be presenting an ion channel drug discovery focused talk at 12.10-12.30 during the British Pharmacology Society track ‘Targeting Ion Channels for Drug Discovery”.
BioWednesday Cambridge: Joint One Nucleus and BioMed Realty Autumn Social
October 16th
Sales and Marketing Manager Dr Sophie Rose will be attending the joint One Nucleus and BioMed Realty social event to be held at Granta Park at the Apiary on 16th October 2019. Sophie will be available during the networking reception to discuss Metrion’s range of ion channel screening services.
Sophion Bioscience Japanese User Meeting 2019
October 11th
Dr Edward Humphries will be presenting at the Sophion Japanese User meeting on Friday 11th October to be held at the Knowledge Capital Conference Rooms at the Grand Front, Osaka. Edd’s talk is entitled: “Advancing Cardiac Safety Screening on the QPatch” Edd will be at the User meeting all day.
BioForward 2019
October 11th
Metrion Biosciences’ Sales and Marketing Manager, Dr Sophie Rose will be attending BioForward on Friday 11th October to be held at the Aston Webb Building at the University of Birmingham. Sophie will be attending the presentations and networking sessions and will be available during the day for meetings to discuss Metrion’s range of ion channel services.
Upcoming events
Metrion Biosciences holds and participates in numerous events each year for professional development, knowledge sharing, self-improvement and networking opportunities. You will find a list of all our upcoming events here, please follow the links to find out more information about any of them.
Let’s work together
What are your specific ion channel and assay needs?
If you have any questions or would like to discuss your specific assay requirements, we will put you directly in touch with a member of our scientific team. Contact us today to discover more.